HROW Q3 2020 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14M+12.9% YoY

Gross Profit

$11M74.3% margin

Operating Income

$2M11.1% margin

Net Income

$9M60.0% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

+78.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$917,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$35M

Stockholders' Equity

$25M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$13M	+12.9%
Gross Profit	$11M	$9M	+23.1%
Operating Income	$2M	-$4M	+136.3%
Net Income	$9M	-$11M	+175.3%

Revenue Segments

Other Revenues

$14,000100%